Nepal on Saturday kicked off a three-day anti-elephantiasis campaign across the nation's 36 districts in a bid to wipe out the disease caused by filarial worms.
According to reports, anti-elephantiasis medicines will be distributed to 13 million people.
The Nepal government since 2003 has launched the campaign against lymphatic filariasis after cases of mosquito-borne disease were traced in 61 districts.
Dr. Baburam Marasini, Director at the Epidemiology and Diseases Control Division of Department of Health Services said that the medicines would be given to folks free of charge, reports the Himalayan Times.
Dr. Marasini also said that medicines against the diseases should be taken in six different phases but the children below two years, aspirant mothers, patients of epilepsy and patients of serious illness should not take these medicines.
A total of 13,078 health workers and 65,678 volunteers have been mobilised to make the campaign a success.
The similar campaign was earlier held in 27 districts.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
